循環器ジャーナル71巻2号

2023年04月発行

特集 今だからこそ聞きたい心不全診療のこと。 Ⅲ．治療

EFをカットオフ値としてICD適応を決める妥当性はどこまであるのか？

著者： 近藤祐介¹

所属機関： ¹千葉大学大学院医学研究院循環器内科学

ページ範囲：P.260 - P.266

POINT
・心臓突然死のリスクを知るうえで，左室駆出率と心臓電気生理学的検査は重要である．
・左室駆出率35〜40%以下の心機能低下は心臓突然死のリスクであり，ICDを考慮する必要がある．
・本邦のレジストリーからみる左室駆出率35%以下の慢性心不全に対するICDの一次予防効果は高い．

参考文献

1）日本循環器学会，日本不整脈心電学会．2022年改訂版 不整脈の診断とリスク評価に関するガイドライン．2022　https://www.j-circ.or.jp/cms/wp-content/uploads/2022/03/JCS2022_Takase.pdf

2）Moss AJ, Zareba W, Hall WJ, et al ; Multicenter Automatic Defibrillator Implantation Trial Ⅱ Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002 ; 346 : 877-83.

3）Bardy GH, Lee KL, Mark DB, et al ; Sudden Cardiac Death in Heart Failure Trial（SCD-HeFT）Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005 ; 352 : 225-37.

4）Ikeda T, Saito H, Tanno K, et al. T-wave alternans as a predictor for sudden cardiac death after myocardial infarction. Am J Cardiol 2002 ; 89 : 79-82.

5）Moss AJ, Hall WJ, Cannom DS, et al ; Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996 ; 335 : 1933-40.

6）Goldenberg I, Gillespie J, Moss AJ, et al ; Executive Committee of the Multicenter Automatic Defibrillator Implantation Trial Ⅱ. Long-term benefit of primary prevention with an implantable cardioverter-defibrillator : an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial Ⅱ. Circulation 2010 ; 122 : 1265-71.

7）Shiga T, Hagiwara N, Ogawa H, et al ; Heart Institute of Japan Acute Myocardial Infarction-Ⅱ（HIJAMI-Ⅱ）Investigators. Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era : results from the HIJAMI-Ⅱ registry. Heart 2009 ; 95 : 216-20.

8）Tanno K, Miyoshi F, Watanabe N, et al ; MADIT Ⅱ. The Multicenter Automtic Defibrillator Implantation Trial. Are the MADIT Ⅱ criteria for ICD implantation appropriate for Japanese patients? Circ J 2005 ; 69 : 19-22.

9）Satake H, Fukuda K, Sakata Y, et al ; CHART-2 Investigators. Current status of primary prevention of sudden cardiac death with implantable cardioverter defibrillator in patients with chronic heart failure--a report from the CHART-2 Study. Circ J 2015 ; 79 : 381-90.

10）Greenberg H, Case RB, Moss AJ, et al ; MADIT-Ⅱ Investigators. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial（MADIT-Ⅱ）. J Am Coll Cardiol 2004 ; 43 : 1459-65.

11）Buxton AE, Lee KL, DiCarlo L, et al ; Multicenter Unsustained Tachycardia Trial Investigators. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. N Engl J Med 2000 ; 342 : 1937-45.

12）Hohnloser SH, Kuck KH, Dorian P, et al ; DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004 ; 351 : 2481-8.

13）日本循環器学会，日本不整脈心電学会．不整脈非薬物治療ガイドライン（2018年改訂版）．2019（2021年9月6日更新）https://www.j-circ.or.jp/cms/wp-content/uploads/2018/07/JCS2018_kurita_nogami.pdf

14）Kadish A, Dyer A, Daubert JP, et al ; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation（DEFINITE）Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004 ; 350 : 2151-8.

15）Køber L, Thune JJ, Nielsen JC, et al ; DANISH Investigators. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med 2016 ; 375 : 1221-30.

16）Desai AS, Fang JC, Maisel WH, et al. Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy : a meta-analysis of randomized controlled trials. JAMA 2004 ; 292 : 2874-9.

17）Golwala H, Bajaj NS, Arora G, et al. Implantable cardioverter-defibrillator for nonischemic cardiomyopathy : An updated meta-analysis. Circulation 2017 ; 135 : 201-3.

18）Kawashiro N, Kasanuki H, Ogawa H, et al ; Heart Institute of Japan--Department of Cardiology（HIJC）Investigators. Clinical characteristics and outcome of hospitalized patients with congestive heart failure : results of the HIJC-HF registry. Circ J 2008 ; 72 : 2015-20.

19）Shiba N, Shimokawa H. Chronic heart failure in Japan : implications of the CHART studies. Vasc Health Risk Manag 2008 ; 4 : 103-13.

20）Noda T, Kurita T, Nitta T, et al. Significant impact of electrical storm on mortality in patients with structural heart disease and an implantable cardiac defibrillator. Int J Cardiol 2018 ; 255 : 85-91.

21）Kondo Y, Noda T, Sato Y, et al. Comparison of 2-year outcomes between primary and secondary prophylactic use of defibrillators in patients with coronary artery disease : A prospective propensity score-matched analysis from the Nippon Storm Study. Heart Rhythm O2 2021 ; 2 : 5-11.

22）Sasaki S, Noda T, Okumura K, et al. Effectiveness of Implantable Cardioverter Defibrillator in Patients With Non-Ischemic Heart Failure With Systolic Dysfunction-Subanalysis of the Nippon Storm Study. Circ J 2022. doi : 10.1253/circj.CJ-22-0187. Online ahead of print.